XSHG
603079
Market cap384mUSD
Sep 30, Last price
13.61CNY
Name
Zhejiang Shengda Bio-pharm Co Ltd
Chart & performance
P/E
41.39
P/S
3.05
EPS
0.33
Div yield, %
0.44%
Shrs. gr., 5y
1.03%
Rev. gr., 5y
-0.53%
Revenues
845m
+2.07%
Net income
62m
+111.24%
CFO
139m
-6.08%
Dividend
Jul 01, 20260.1 CNY/sh
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Zhejiang Shengda Bio-Pharm Co., Ltd., based in Tiantai, China, is a global enterprise dedicated to the research, development, manufacturing, and distribution of a diverse range of food and animal feed additives. The company's comprehensive product portfolio includes essential vitamins like biotin and folic acid, biological preservation agents such as nisin and natamycin, and intermediate Active Pharmaceutical Ingredients (APIs). They also provide various natural solutions for food preservation.
Key people
Ai Hong
Chairman of the Board
Guihua Xu
Finance Director
Bin Zhou
General Manager · since 2019
Han Pang
Deputy General Manager · since 2018
Jing Zhu
Deputy General Manager, Director · since 2019
Director · since 2013
Independent Director
Guohua Hu
Independent Director
Independent Director · since 2015
Valuation
Title CNY in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||